BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 16227210)

  • 1. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system.
    Siddiq A; Ayoub IA; Chavez JC; Aminova L; Shah S; LaManna JC; Patton SM; Connor JR; Cherny RA; Volitakis I; Bush AI; Langsetmo I; Seeley T; Gunzler V; Ratan RR
    J Biol Chem; 2005 Dec; 280(50):41732-43. PubMed ID: 16227210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prolyl 4-hydroxylase expression and differential regulation of hypoxia-inducible factors in the aged rat brain.
    Ndubuizu OI; Chavez JC; LaManna JC
    Am J Physiol Regul Integr Comp Physiol; 2009 Jul; 297(1):R158-65. PubMed ID: 19420289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways.
    Siddiq A; Aminova LR; Troy CM; Suh K; Messer Z; Semenza GL; Ratan RR
    J Neurosci; 2009 Jul; 29(27):8828-38. PubMed ID: 19587290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
    Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
    Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia.
    Kunze R; Zhou W; Veltkamp R; Wielockx B; Breier G; Marti HH
    Stroke; 2012 Oct; 43(10):2748-56. PubMed ID: 22933585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS; Kiriakidis S; Paleolog EM; Davies AH
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic stabilization of hypoxia-inducible transcription factors protects developing mouse brain from hypoxia-induced apoptotic cell death.
    Trollmann R; Richter M; Jung S; Walkinshaw G; Brackmann F
    Neuroscience; 2014 Oct; 278():327-42. PubMed ID: 25162122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner.
    Frump AL; Selej M; Wood JA; Albrecht M; Yakubov B; Petrache I; Lahm T
    Am J Respir Cell Mol Biol; 2018 Jul; 59(1):114-126. PubMed ID: 29394091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin.
    Zaman K; Ryu H; Hall D; O'Donovan K; Lin KI; Miller MP; Marquis JC; Baraban JM; Semenza GL; Ratan RR
    J Neurosci; 1999 Nov; 19(22):9821-30. PubMed ID: 10559391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor.
    Fukui K; Shinozaki Y; Kobayashi H; Deai K; Yoshiuchi H; Matsui T; Matsuo A; Matsushita M; Tanaka T; Nangaku M
    Eur J Pharmacol; 2019 Sep; 859():172532. PubMed ID: 31301309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases.
    Koivunen P; Hirsilä M; Günzler V; Kivirikko KI; Myllyharju J
    J Biol Chem; 2004 Mar; 279(11):9899-904. PubMed ID: 14701857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.
    Souvenir R; Flores JJ; Ostrowski RP; Manaenko A; Duris K; Tang J
    Transl Stroke Res; 2014 Feb; 5(1):118-27. PubMed ID: 24323731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1 regulates hypoxia-inducible factor-1α and -2α stability through prolyl hydroxylase domain 2 inhibition in human lymphatic endothelial cells.
    Caprara V; Scappa S; Garrafa E; Di Castro V; Rosanò L; Bagnato A; Spinella F
    Life Sci; 2014 Nov; 118(2):185-90. PubMed ID: 24607784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypoxia-inducible factor-α prolyl hydroxylase inhibitor FG4592 ameliorates renal fibrosis by inducing the H3K9 demethylase JMJD1A.
    Ike T; Doi S; Nakashima A; Sasaki K; Ishiuchi N; Asano T; Masaki T
    Am J Physiol Renal Physiol; 2022 Nov; 323(5):F539-F552. PubMed ID: 36074918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia.
    Zuk A; Si Z; Loi S; Bommegowda S; Hoivik D; Danthi S; Molnar G; Csizmadia V; Rabinowitz M
    J Pharmacol Exp Ther; 2022 Oct; 383(1):11-24. PubMed ID: 35926869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
    Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
    Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response.
    Kuiper C; Dachs GU; Currie MJ; Vissers MC
    Free Radic Biol Med; 2014 Apr; 69():308-17. PubMed ID: 24495550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A screen for inducers of p21(waf1/cip1) identifies HIF prolyl hydroxylase inhibitors as neuroprotective agents with antitumor properties.
    Ma TC; Langley B; Ko B; Wei N; Gazaryan IG; Zareen N; Yamashiro DJ; Willis DE; Ratan RR
    Neurobiol Dis; 2013 Jan; 49():13-21. PubMed ID: 22944173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.
    Yu X; Fang Y; Liu H; Zhu J; Zou J; Xu X; Jiang S; Ding X
    Nephrol Dial Transplant; 2012 Aug; 27(8):3110-9. PubMed ID: 22399494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic preconditioning produces differential expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and its regulatory enzyme HIF prolyl hydroxylase 2 in neonatal rat brain.
    Jones NM; Lee EM; Brown TG; Jarrott B; Beart PM
    Neurosci Lett; 2006 Aug; 404(1-2):72-7. PubMed ID: 16828226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.